Supriya Lifescience Limited

BSE: 543434 NSE: SUPRIYA
Supriya Lifescience Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L51900MH2008PLC180452 Incorporated 26 March 2008 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: SUPRIYA · BSE: 543434 Public Limited Company pharma
Data last updated
Market Cap
₹7,493 Cr
SUPRIYA · NSE
Share Price
₹925.00
-2.66% today
Revenue
₹828 Cr
FY 2025-26 · +22.5% YoY
EBITDA
₹294 Cr
Margin 35.6%
Net Profit
₹209 Cr
FY 2025-26 · +11.3% YoY
P/E (TTM)
38.5x
P/B 6.4x
ROE
19.1%
ROCE 25.1%
Debt / Equity
0.00
Interest cover 1.0x

About Supriya Lifescience Limited

Data last updated:

Supriya Lifescience Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 26 March 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L51900MH2008PLC180452. Its GSTIN is 27AALCS8686A1ZX (Maharashtra). Its shares are listed on BSE: 543434 and NSE: SUPRIYA.

The company has an authorised share capital of ₹35 Cr and a paid-up capital of ₹16.1 Cr. It is led by directors including Saloni Satish Wagh (Managing Director) and Shivani Satish Wagh (Managing Director).

Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 207/208 Udyog Bhavan Sonawala Road Goregaon (East), Mumbai, Maharashtra, India – 400063.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹827.87 Cr, a growth of 18.86% compared to the previous year. The net worth stands at ₹1,197.74 Cr (up 20.16% YoY). Total assets are valued at ₹1,205.07 Cr (up 20.09% YoY).

The company has about 450 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Supriya Lifescience. As per MCA filings, the company has open charges of ₹262.41 Cr and satisfied charges of ₹169.96 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website supriyalifescience.com.

Company Details of Supriya Lifescience Limited
CIN L51900MH2008PLC180452
Registration Number 180452
Incorporation Date 26 March 2008
ROC Mumbai
Listing Status Listed (BSE: 543434, NSE: SUPRIYA)
Company Status Active
Date of Last AGM 24 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Saloni Satish Wagh Managing Director Shivani Satish Wagh Managing Director Smita Satish Wagh Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    supriyalifescience.com
  • Social Media
  • Registered Address
    207/208 Udyog Bhavan Sonawala Road Goregaon (East), Mumbai, Maharashtra, India – 400063
  • Industry
    Pharma, API Manufacturers
Company report
Supriya Lifescience Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Supriya Lifescience Limited report

Financials, compliance, directors, charges, ownership and filings for Supriya Lifescience Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Supriya Lifescience

Supriya Lifescience has one previous CIN (Corporate Identification Number): U51900MH2008PLC180452. The current CIN is L51900MH2008PLC180452, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L51900MH2008PLC180452Current
U51900MH2008PLC180452Previous

Associated Brands with Supriya Lifescience

Supriya Lifescience operates one associated brand: Supriya Lifescience. Each brand links to its own profile.

BrandDescriptionWebsite
Supriya Lifescience
Active pharmaceutical ingredients and intermediates are manufactured.supriyalifescience.com

Business Activity of Supriya Lifescience

The main business activity of Supriya Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details for Supriya Lifescience Limited

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Supriya Lifescience

Supriya Lifescience Limited is audited by Kakaria and Associates LLP for the financial year 2024.

NameStatusAppointment DateCessation Date
Kakaria and Associates LLPLockedLockedLocked
Premium access

Complete auditor history for Supriya Lifescience Limited

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Supriya Lifescience Limited

Supriya Lifescience has 10 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Smita Satish Wagh
Also directs: Supriya Medi-Chem Private Limited
Whole-Time Director26 Mar 200818 Years 6 MonthsCurrent
Neelam Yashpal Arora
Also directs: Kesar Petroproducts Limited, Shreyas Intermediates Limited, Novel Bio Fuels Limited
Director25 Mar 20215 Years 6 MonthsCurrent
Balasaheb Gulabrao SawantWhole-Time Director26 May 20233 Years 4 MonthsCurrent
Satish Waman Wagh
Also directs: Supriya Medi-Chem Private Limited, Sachin Industries Limited, Global Gsa Services India Private Limited and 3 more
Whole-Time Director26 Mar 200818 Years 6 MonthsCurrent
Saloni Satish WaghManaging Director01 Jul 20224 Years 3 MonthsCurrent
Shivani Satish WaghManaging Director01 Jul 20224 Years 3 MonthsCurrent
Showing 6 of 10 current directors. View all directors

Financials of Supriya Lifescience Limited FY 2025-26 filings available

Supriya Lifescience Limited reported revenue of ₹827.87 Cr (up 18.86% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹828 Cr
+18.9% YoY
EBITDA
₹294 Cr
+12.9% YoY
Profit After Tax
₹209 Cr
+11.3% YoY
Net Worth
₹1,198 Cr
+20.2% YoY
Total Assets
₹1,205 Cr
+20.1% YoY
Total Debt
₹5.44 Cr
+1.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue828696570461530391312
Revenue growth+22.5%+10.5%+18.8%+5.1%+44.9%+2.3%+45.2%
EBITDA29426117612921417398.38
EBITDA margin+35.6%+37.5%+30.9%+28.0%+40.4%+44.3%+31.6%
Profit before tax27524816612320716796.19
Net profit20918811989.9415212473.35
Net profit margin+25.3%+27.0%+20.9%+19.5%+28.6%+31.6%+23.5%
EPS (₹)25.9823.3514.8011.1618.8616.8950.11
Balance sheet
Total assets1,2051,003822728646362253
Net worth1,198997815699616269149
Total debt5.445.385.4922.4727.4272.1982.21
Cash & bank78.8779.1574.9615822889.2874.71
Net working capital412355321386420190120
Cash flow
Cash from operations18616511363.6148.8075.89117
Cash from investing(176)(152)(174)(124)(59.82)(46.80)(25.14)
Cash from financing(9.88)(8.23)(22.36)(10.28)150(14.52)(29.23)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue190277206200145184186166
Revenue growth (YoY)+30.8%+50.2%+11.2%+20.3%-9.7%+16.4%+32.5%+18.6%
Other income2.653.482.612.732.672.982.102.52
Total expenses14217913512793.37117120101
EBITDA47.4697.6271.6272.6451.7067.5865.9564.71
EBITDA margin+25.0%+35.3%+34.7%+36.4%+35.6%+36.7%+35.5%+39.0%
Depreciation8.948.506.826.646.456.084.964.74
Interest0.370.470.490.420.510.420.510.43
Profit before tax40.8092.1366.9268.3147.4164.0662.5862.06
Tax16.7517.9017.2417.8912.6313.6815.8015.92

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 03 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue190277206200145184186166
Revenue growth (YoY)+30.8%+50.2%+11.2%+20.3%-9.7%+16.4%+32.5%+18.6%
Other income2.653.482.612.732.672.982.102.52
Total expenses14217913512793.37117120101
EBITDA47.4697.6271.6272.6451.7067.5865.9564.71
EBITDA margin+25.0%+35.3%+34.7%+36.4%+35.6%+36.7%+35.5%+39.0%
Depreciation8.948.506.826.646.456.084.964.74
Interest0.370.470.490.420.510.420.510.43
Profit before tax40.8092.1366.9268.3147.4164.0662.5862.06
Tax16.7517.9017.2417.8912.6313.6815.8015.92
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue828696570461530391312
Revenue growth+22.5%+10.5%+18.8%+5.1%+44.9%+2.3%+45.2%
Other income11.499.8210.649.497.585.0111.07
Total expenses533436394332316218213
Employee cost96.6880.5267.6455.5849.0832.7618.88
EBITDA29426117612921417398.38
EBITDA margin+35.6%+37.5%+30.9%+28.0%+40.4%+44.3%+31.6%
Depreciation28.4120.4415.8111.8210.126.766.41
Interest2.771.815.153.084.204.086.85
Profit before tax27524816612320716796.19
Tax65.6660.5346.5833.6355.4443.7122.84
Net profit20918811989.9415212473.35
Net profit margin+25.3%+27.0%+20.9%+19.5%+28.6%+31.6%+23.5%
EPS (₹)25.9823.3514.8011.1618.8616.8950.11
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital16.1016.1016.1016.1016.1014.6414.64
Reserves & surplus1,182981799683600254134
Shareholders' funds (net worth)1,198997815699616269149
Secured loans0.000.000.0016.6321.3066.3878.12
Unsecured loans5.445.385.495.846.125.814.09
Total debt5.445.385.4922.4727.4272.1982.21
Total liabilities--822728646362253
Assets
Gross block799534371306223123115
Net block68945331026219010098.58
Capital work in progress35.5514814967.6343.4178.7940.21
Investments98.5263.2463.8025.300.050.050.05
Inventories16011885.2511692.3172.4849.46
Sundry debtors21913411284.6611573.5051.63
Cash & bank balances78.8779.1574.9615822889.2874.71
Loans & advances74.3911012610762.1430.2119.81
Total current assets532442398465498265196
Total current liabilities12186.8776.6478.8077.5875.9075.57
Net working capital412355321386420190120
Total assets1,2051,003822728646362253
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash79.1574.9615822889.2874.7112.40
Net cash from operating activities18616511363.6148.8075.89117
Net cash from investing activities(176)(152)(174)(124)(59.82)(46.80)(25.14)
Net cash from financing activities(9.88)(8.23)(22.36)(10.28)150(14.52)(29.23)
Net change in cash(0.29)4.20(82.63)(70.33)13914.5762.31
Closing cash78.8779.1574.9615822889.2874.71
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+18.9%+22.1%+23.7%-13.0%+35.5%+25.5%+12.2%
EBITDA growth+12.9%+48.2%+36.6%-39.8%+23.6%+76.0%-24.9%
PBT growth+10.6%+50.0%+34.2%-40.4%+23.9%+73.9%-22.0%
Net income growth+11.3%+57.8%+32.4%-40.8%+22.8%+68.5%-30.6%
Revenue CAGR (3Y)+21.6%+9.5%+13.4%+13.9%+24.0%+22.5%+19.3%
EBITDA CAGR (3Y)+31.7%+6.8%+0.6%+9.4%+17.8%+99.1%+78.2%
Profitability & leverage
Net income margin+25.3%+27.0%+20.9%+19.5%+28.6%+31.6%+23.5%
Return on capital employed+25.1%+27.4%+22.1%+18.4%+42.0%+55.8%+46.5%
Return on net worth+19.1%+20.7%+15.7%+13.7%+34.3%+59.2%+60.4%
Debt / equity0.000.010.020.040.110.370.71
Long-term debt / equity0.000.010.010.010.010.010.04
Interest cover1.040.753.212.632.062.457.45
Efficiency & per share
Fixed asset turnover1.371.731.911.953.403.622.98
Inventory turnover6.587.686.444.967.147.077.77
Debtors turnover5.176.366.595.176.246.895.59
EPS (₹)25.9823.3514.8011.1618.8616.8950.11
Dividend per share (₹)1.001.000.800.600.600.5410.00
Book value per share (₹)148.81123.84101.3186.9176.5036.70101.84
Want more history and ratios?
You're viewing the latest exchange-filed financials for Supriya Lifescience Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Supriya Lifescience Limited

Shareholding for the quarter ended Sep 2026: promoters hold 68.30%, foreign institutional investors hold 6.20%, domestic institutional investors hold 5.30% and retail and other public shareholders hold 20.20%.

Promoters: 68.30%DII (Domestic Institutional): 5.30%FII (Foreign Institutional): 6.20%Retail & Others: 20.20%
Sep 2026
QUARTER
68.30% Promoters
5.30% DII (Domestic Institutional)
6.20% FII (Foreign Institutional)
20.20% Retail & Others
Promoter holding - history
Now 68.30% · Sep 2026High 68.30% · Dec 2025Low 68.30% · Dec 2025
67%67.8%68.5%69.3%70%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 68.30%Mar 2026: 68.30%Jun 2026: 68.30%Sep 2026: 68.30%68.30%68.30%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters68.30%68.30%68.30%68.30%
Public31.70%31.70%31.70%31.70%

Charges & Borrowings of Supriya Lifescience

Open charges
₹262.41 Cr
Satisfied charges
₹169.96 Cr
Breakdown by lending institutions
Idbi Trusteeship Services Limited₹114.00 Cr
Others₹87.00 Cr
Axis Bank Limited₹44.00 Cr
The Saraswat Cooperative Bank Ltd₹12.91 Cr
The Saraswat Co-Op Bank Ltd₹4.50 Cr
Latest charge details
DateLenderAmountStatus
26 Jun 2025Idbi Trusteeship Services Limited₹114 CrOpen
03 May 2024Axis Bank Limited₹44 CrOpen
17 Apr 2024Others₹30 CrOpen
05 Jul 2012The Saraswat Cooperative Bank Ltd₹2 CrOpen
27 Jun 2009The Saraswat Cooperative Bank Ltd₹10.91 CrOpen

Total charge records: 45 View all charges

Employees and EPFO Compliance at Supriya Lifescience

Supriya Lifescience Limited has a workforce of 450 employees as of Apr 04, 2025.

Employee count
450
Active EPFO establishments
1
Employee growth
12.78%
Premium access

Employee and EPFO history for Supriya Lifescience Limited

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Supriya Lifescience

Supriya Lifescience has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
Cancelled / inactive
0
GSTINStateStatusRegistered on
27AALCS8686A1ZXMaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance for Supriya Lifescience Limited

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Supriya Lifescience

Premium access

Credit ratings, litigation, and regulatory alerts for Supriya Lifescience Limited

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Supriya Lifescience

Premium access

MSME payment history for Supriya Lifescience Limited

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Supriya Lifescience

Premium access

Corporate group structure for Supriya Lifescience Limited

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Supriya Lifescience

Premium access

MCA filings and documents for Supriya Lifescience Limited

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Supriya Lifescience

Directors
09 Feb 2026
Manish Ishwarlal Panchal was appointed as a Additional Director on 09 Feb 2026 & has been associated with this company since 7 months 25 days.
Directors
09 Feb 2026
Kothandaraman Hari was appointed as a Additional Director on 09 Feb 2026 & has been associated with this company since 7 months 25 days.
Activity
24 Sep 2025
Supriya Lifescience Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records.
Charges
26 Jun 2025
A charge with Idbi Trusteeship Services Limited amounted to Rs. 114.00 Cr with Charge ID 101126368 was registered on 26 Jun 2025.
Activity
31 Mar 2025
Supriya Lifescience Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Directors
17 Mar 2025
Prachi Suhas Sathe was appointed as a Company Secretary on 17 Mar 2025 & has been associated with this company since 1 year 6 months.

Recent News on Supriya Lifescience

Frequently Asked Questions about Supriya Lifescience Limited

Supriya Lifescience is an active public limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 26 March 2008 (18+ years old) and is registered under CIN L51900MH2008PLC180452. Listed on BSE: 543434 and NSE: SUPRIYA.

Supriya Lifescience reported revenue of ₹827.87 Cr for FY 2025-26 (up 18.86% YoY) based on standalone financials.

Supriya Lifescience has 10 current directors:

The GSTIN of Supriya Lifescience is 27AALCS8686A1ZX, registered in Maharashtra.

The CIN (Corporate Identification Number) of Supriya Lifescience is L51900MH2008PLC180452. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Supriya Lifescience is listed on both BSE (code: 543434) and NSE (symbol: SUPRIYA).

Supriya Lifescience was incorporated on 26 March 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.

Supriya Lifescience can be reached through the website supriyalifescience.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Supriya Lifescience is at 207208 Udyog Bhavan Sonawala Road Goregaon East, Mumbai, Maharashtra, India – 400063.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available